The summit convenes senior executives from healthcare, biotechnology, artificial intelligence, academia, and investment firms under the theme “Healthtech Frontiers: Building the Health Ecosystem of Tomorrow.”
The hospital’s team modified the patient’s hematopoietic stem cells to correct the underlying genetic defect, then reinfused the corrected cells back into the body.
The SEEG procedure operates as a sophisticated mapping tool, allowing neurosurgeons to precisely identify the exact regions of the brain responsible for triggering seizures.
The Board’s decision to extend Dr. Zoëga’s appointment reflects confidence in both his individual leadership and the broader executive team’s capabilities.
The international event brings together leading experts and practitioners from around the world to share knowledge, advance modern surgical techniques, and shape the future of robotic surgery.